HUDSON TECHNOLOGIES INC /NY financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data HUDSON TECHNOLOGIES INC /NY files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	105	140	167	162	148	193	325	289	237	247
Cost of revenue	74.4	102				121	162	178	171	185
Gross profit	31.1	38	-7.37	17.2	35.4	71.7	163	112	65.7	62.1
Selling, general and administrative	11.7	21.7	32.3	30	26.6	26.6	28.6	30.5	33	40.2
Selling and marketing	4.31
General and administrative	7.83
Operating expenses	12.1	22.9	35.2	32.9	29.5	29.4	31.4	33.3	36.4	43.5
Operating income	18.9	15.1	-42.6	-15.8	5.9	42.3	132	78.2	29.3	18.6
Interest expense	1.12	3.16	14.8	18.9	12.3	11.4	14.3	8.35
Other non-operating income	-1.68	-3.13	-14.8			-8.91	-14.3	-8.35	2.73	4.13
Pre-tax income	17.3	12	-57.4	-25.3	-5.39	33.4	117	69.8	32	22.7
Income tax	6.63	0.85	-1.7	0.66	-0.19	1.14	13.4	17.6	7.64	6.02
Net income	10.6	11.2	-55.7	-25.9	-5.21	32.3	104	52.2	24.4	16.7
EBITDA	20.7	17.4	-38.5	-11.6	9.14	45.7	135	81.2	32.3	21.3
EPS, basic	0.31	0.27	-1.31	-0.61	-0.12	0.74	2.31	1.15	0.54	0.38
EPS, diluted	0.30	0.26	-1.31	-0.61	-0.12	0.69	2.20	1.10	0.52	0.37
Shares, basic (weighted)	34.1	41.8	42.5	42.6	42.7	43.8	45	45.4	45.3	43.6
Shares, diluted (weighted)	35.4	42.8	42.5	42.6	42.7	46.6	47.1	47.3	47.1	45.1

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	33.9	5	2.27	2.6	1.35	3.49	5.3	12.4	70.1	39.5
Receivables	4.8	14.8	14.1	8.06	9.81	14.2	20.9	25.2	13.6	17.1
Inventory	68.6	172	102	59.2	44.5	94.1	145	154	96.2	136
Other current assets	0.85	6.93	5.29	4.53	6.53	8.09	5.29	7.49	9.22	12.4
Total current assets	108	209	124	74.4	62.1	120	177	205	196	211
Property, plant and equipment	7.53	30.5	27.4	23.7	21.9	20.1	20.6	19.4	21.6	23.6
Lease right-of-use assets			0	8.05	6.56	6.8	7.34	6.59	6.88	5.29
Goodwill	0.86	49.5	47.8	47.8	47.8	47.8	47.8	47.8	62.3	65.3
Intangible assets	3.3	32.4	29.5	26	23.2	20.4	17.6	14.8	14.1	11.3
Other non-current assets	0.08	0.18	0.11	0.19	0.09	0.71	2.39	3.14	2.33	2.32
Total assets	122	321	228	180	162	216	272	297	303	319
Accounts payable	5.11	10.9	8.67	10.3	7.64	9.62	14.2	23.4	8.69	21.1
Accrued liabilities	1.78	3.05	1.05	0.72	5.33	14	11.7	12.3	12.3	14.1
Short-term debt	0.2	66.2	31.7	17	9.31	20.2	4.25
Total current liabilities	10.3	95.4	60.4	46.1	37.8	64.4	52.6	58.6	47.8	64.6
Long-term debt	0.15	101	98.3	82	78	73.1	39
Lease liabilities			0	5.74	3.93	5.5	5.76	4.79	4.92	3.23
Other non-current liabilities	0									1.8
Total liabilities	10.5	198	159	135	121	145	97.6	67.9	56.8	75.3
Total debt	0.35	102	101	85	85.3	78.4	43.2
Paid-in capital	114	114	116	118	118	116	116	118	111	91.7
Retained earnings	-2.43	8.73	-46.9	-72.9	-78.1	-45.8	58	110	135	151
Shareholders' equity	112	123	69.2	45.1	40.6	70.9	175	229	246	243
Total equity	112	123	69.2	45.1	40.6	70.9	175	229	246	243
Total liabilities and equity	122	321	228	180	162	216	272	297	303	319
Shares outstanding	41.5	42.4	42.6	42.6	43.3	44.8	45.3	45.5	44.3	41.6

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	10.6	11.2	-55.7	-25.9	-5.21	32.3	104	52.2	24.4	16.7
Depreciation and amortization	1.74	2.27	4.16	4.19	3.23	3.39	3.18	2.99	3	2.7
Stock-based compensation	0.71	1.5	1.4	1.83	0.66	0.51	0.92	2.31	0.84	1.1
Deferred income tax	1.08	4.01	-1.03	0.75	0.16	0.34	-1.45	4.31	-0.48	-0.04
Change in receivables	-0.4	4.5	0.29	6.08	-2.63	-4.46	-7.12	-4.96	12.3	-3.78
Change in inventory	-6.7	-0.84	43.3	43.5	18.7	-46.9	-53.1	-6.81	60.2	-40.9
Change in payables	0.17	6.51	-0.42	-1.05	-0.7	16.4	4.53	9.46	-12.7	20.2
Cash from operations	9.35	18.4	36.3	33.8	11.7	-1.23	62.8	58.5	91.8	-3.16
Capital expenditures	-1.73	-1.02	-1.09	-1.01	-1.47	-1.92	-3.66	-3.58	-5.3	-5.05
Acquisitions	0	-209	0						-20.7	-2.24
Cash from investing	-1.73	-210	-1.09	-1.01	-0.47	-1.92	-3.66	-3.58	-26	-7.29
Debt issued	0.06	105	0				100
Debt repaid	-4.35	-0.17	-0.89	-16.1	-3.01	-5.25	-148	-47.2
Stock issued	51.1	0.81	0.02	0.01	0.06	0.2	0.18	0.04		0.05
Share buybacks									-8.15	-20
Cash from financing	25.1	163	-38	-32.5	-12.5	5.29	-57.4	-47.8	-8.15	-20.2
Net change in cash	32.7	-28.9	-2.73	0.33	-1.25	2.14	1.8	7.15	57.7	-30.7
Free cash flow	7.62	17.3	35.2	32.8	10.2	-3.15	59.2	55	86.5	-8.21
Interest paid	0.96	2.03	13.6	15.2	11.4	10.2	11.7	4.48	0.69	0.52
Income taxes paid	4.99	6.83	-10.3	-0.2	-0.05	0.13	15.5	18.5	8.99	5.75

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $5.16 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	23.3%	Gross profit / revenue.
Operating margin	4.5%	Operating income / revenue.
EBITDA margin	5.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.7%	Pre-tax income / revenue.
Net margin	3.5%	Net income / revenue.
FCF margin	-13.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-11.6%	Cash from operations / revenue.
Effective tax rate	38.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	3.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.8%	Net income / average total assets.
Return on invested capital (ROIC)	3.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	17.4%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.9%	Capital expenditures / revenue.
D&A / revenue	1.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	4.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-8.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	10.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-5.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-27.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	11.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-36.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-47.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	25.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-34.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-46.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	18.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-31.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-45.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-28.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-44.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-103.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-109.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-1.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	11.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	43.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	5.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	5.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	14.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.23x	Current assets / current liabilities.
Quick ratio	1.02x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.38x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	24.5%	Total liabilities / total assets.
Working capital	$150.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	23.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$168.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.80x	Revenue / average total assets.
Fixed asset turnover	11.6x	Revenue / average property, plant and equipment.
Inventory turnover	1.54x	Cost of revenue / average inventory.
Days inventory	237 days	365 x average inventory / cost of revenue.
Receivables turnover	5.94x	Revenue / average receivables.
Days sales outstanding	61 days	365 x average receivables / revenue.
Days payables	41 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	257 days	Days inventory + days sales outstanding - days payables.
FCF conversion	-382.7%	Free cash flow / net income, when net income is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.21	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$6.09	Revenue / diluted weighted shares.
FCF per share	-$0.82	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$0.70	Cash from operations / diluted weighted shares.
Book value per share	$5.78	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$4.00	Tangible book value / shares outstanding.
Cash per share	$0.61	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$217.2M	Share price x shares outstanding.
Enterprise value	$191.6M	Market cap + total debt - cash - short-term investments.
P/E	24.1x	Market cap / net income. Only when net income is positive.
P/S	0.85x	Market cap / revenue.
P/B	0.89x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.29x	Market cap / tangible book value, when positive.
EV/Sales	0.75x	Enterprise value / revenue.
EV/EBIT	16.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.1x	Enterprise value / EBITDA, when both are positive.
FCF yield	-15.9%	Free cash flow / market cap.
Earnings yield	4.2%	Net income / market cap (the inverse of P/E).
Shareholder yield	8.3%	(Dividends paid + share buybacks) / market cap.

What was HUDSON TECHNOLOGIES INC /NY's revenue in fiscal 2025?

HUDSON TECHNOLOGIES INC /NY reported revenue of $246.6M for fiscal 2025, 4% higher than the year before.

Was HUDSON TECHNOLOGIES INC /NY profitable in fiscal 2025?

Yes. Net income was $16.7M, a net margin of 6.8%.

How much free cash flow did HUDSON TECHNOLOGIES INC /NY generate in fiscal 2025?

Cash from operations of $3.2M minus capital expenditures of $5.1M left free cash flow of -$8.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to HUDSON TECHNOLOGIES INC /NY